Publication

Trefoil factor 3 promotes metastatic seeding and predicts poor survival outcome of patients with mammary carcinoma

Pandey, V
Wu, Z.-S
Zhang, M
Li, R
Zhang, J
Zhu, T
Lobie, P.E
Citations
Altmetric:
Alternative Title
Abstract
Introduction: Recurrence or early metastasis remains the predominant cause of mortality in patients with estrogen receptor positive (ER+) mammary carcinoma (MC). However, the molecular mechanisms underlying the initial progression of ER+ MC to metastasis remains poorly understood. Trefoil factor 3 (TFF3) is an estrogen-responsive oncogene in MC. Herein, we provide evidence for a functional role of TFF3 in metastatic progression of ER+ MC. Methods: The association of TFF3 expression with clinicopathological parameters and survival outcome in a cohort of MC patients was assessed by immunohistochemistry. The expression of TFF3 in MCF7 and T47D cells was modulated by forced expression or siRNA-mediated depletion of TFF3. mRNA and protein levels were determined using qPCR and western blot. The functional effect of modulation of TFF3 expression in MC cells was determined in vitro and in vivo. Mechanistic analyses were performed using reporter constructs, modulation of signal transducer and activator of transcription 3 (STAT3) expression, and pharmacological inhibitors against c-SRC and STAT3 activity. Results: TFF3 protein expression was positively associated with larger tumour size, lymph node metastasis, higher stage, and poor survival outcome. Forced expression of TFF3 in ER+ MC cells stimulated colony scattering, cell adhesion to a Collagen I-coated matrix, colony formation on a Collagen I- or Matrigel-coated matrix, endothelial cell adhesion, and transmigration through an endothelial cell barrier. In vivo, forced expression of TFF3 in MCF7 cells stimulated the formation of metastatic nodules in animal lungs. TFF3 regulation of the mRNA levels of epithelial, mesenchymal, and metastatic-related genes in ER+ MC cells were consistent with the altered cell behaviour. Forced expression of TFF3 in ER+ MC cells stimulated phosphorylation of c-SRC that subsequently increased STAT3 activity, which lead to the downregulation of E-cadherin. siRNA-mediated depletion of TFF3 reduced the invasiveness of ER+ MC cells. Conclusions: TFF3 expression predicts metastasis and poor survival outcome of patients with MC and functionally stimulates cellular invasion and metastasis of ER+ MC cells. Adjuvant functional inhibition of TFF3 may therefore be considered to ameliorate outcome of ER+ MC patients. © 2014 Pandey et al.
Keywords
estrogen receptor, messenger RNA, protein tyrosine kinase, STAT3 protein, trefoil factor 3 protein, trefoil peptide, unclassified drug, uvomorulin, cadherin, CDH1 protein, human, CSK tyrosine-protein kinase, peptide, protein tyrosine kinase, STAT3 protein, STAT3 protein, human, TFF3 protein, human, adult, animal experiment, animal model, animal tissue, Article, breast cancer cell line, breast carcinoma, cancer prognosis, cancer staging, cell adhesion, cell invasion, cell migration, colony formation, controlled study, down regulation, endothelium cell, gene expression, human, human cell, human tissue, lung metastasis, lymph node metastasis, major clinical study, marker gene, metastasis, mouse, nonhuman, oncogene, overall survival, protein expression, protein phosphorylation, recurrence free survival, tumor volume, animal, Bagg albino mouse, breast tumor, cancer transplantation, disease free survival, female, genetics, Kaplan Meier method, lung tumor, MCF 7 cell line, metabolism, middle aged, mortality, nude mouse, Paget nipple disease, pathology, phosphorylation, physiology, proportional hazards model, protein processing, secondary, tumor invasion, Animals, Breast Neoplasms, Cadherins, Carcinoma, Ductal, Breast, Disease-Free Survival, Female, Gene Expression, Humans, Kaplan-Meier Estimate, Lung Neoplasms, Lymphatic Metastasis, MCF-7 Cells, Mice, Inbred BALB C, Mice, Nude, Middle Aged, Neoplasm Invasiveness, Neoplasm Transplantation, Peptides, Phosphorylation, Proportional Hazards Models, Protein Processing, Post-Translational, src-Family Kinases, STAT3 Transcription Factor
Source Title
Breast Cancer Research
Publisher
Series/Report No.
Organizational Units
Organizational Unit
PHARMACOLOGY
dept
Organizational Unit
Rights
Attribution 4.0 International
Date
2014
DOI
10.1186/s13058-014-0429-3
Type
Article
Additional Links
Related Datasets
Related Publications